Under USA Fencing's current eligibility policy, what are the medical requirements for transgender women to compete in women's events, including the required treatment and its duration? Additionally, what is the effective date of the revised Transgender & Non-Binary Athlete Eligibility Policy?
Navigate to the 'Transgender and Non-Binary Policy' page on usafencing.org. Locate the 'Current Transgender & Non-Binary Athlete Eligibility Policy' section. Within the current policy, find the section detailing requirements for 'Junior, Senior and Veteran athletes'. Identify the medical treatment and its required duration for 'Transgender female (MTF) athletes' to compete in women's events. Locate the effective date of the 'Revised Transgender & Non-Binary Athlete Eligibility Policy' as stated on the page. State the required medical treatment, its duration, and the effective date of the revised policy.
State that transgender women (MTF) must be treated with testosterone suppression medication. State that this treatment must be completed for one calendar year (12 months). State that the effective date of the revised policy is April 15, 2025.